Search results for: 'plan screening'

Where there is smoke, there is fire. Businesses must recognize DDoS attacks for the data security threat that they are, instead of the simple nuisances of earlier years. In this insight, Stratecast |Frost & Sullivan details the growing threat from smoke screen DDoS attacks, and offers business leaders recommendations for properly understanding DDoS...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

All economic and development strategies, even if pre-existing the National Development Plan (NDP), now fall under the NDP umbrella. Aligned with the NDP objectives to achieve sustainable growth and to combat unemployment, the Industrial Policy Action Plan (IPAP) envisions how to reverse industrial decline in general, but specifically in 19 sectors ...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

Rising healthcare and surgery costs are increasing the burden on healthcare systems, making it difficult for hospitals to offer high-quality care at affordable prices. Time-consuming manual processes that significantly impact surgeon time and workload, hospital cost increases due to delayed surgery, and low patient satisfaction levels due to human ...

Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...

This study reports the findings of a major Frost & Sullivan survey conducted during 2019. The survey was conducted in the U.S. and Europe (England, Germany, France) and had the following objectives: o Measure the current use of--and future decision-making behavior toward--mobile worker applications and devices o Uncover preferences and plans reg...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...